Abstract: A composition, comprising L-alanine or a salt thereof, L-glutamine or a salt thereof, and an oligopeptide containing either a L-alanine residue or a L-glutamine residue, or both, is disclosed. A composition made up of (i) L-alanine or a salt thereof, (ii) L-glutamine or a salt thereof, and (iii) an oligopeptide containing a L-alanine or a L-glutamine residue is also discloed. The L-alanine and the L-glutamine are present in these compositions in an available molar ratio of from 1:0.1 to 1:10, respectively. These compositions are useful in the therapy or prevention of hepatic disorders.

Abstract: A pharmaceutical composition for preventing or alleviating the effects of acute alcoholism, in particular liver disturbances in mammals, which comprises a mixture of alanine or a pharmaceutically acceptable salt or derivative thereof capable of effectively acting as alanine in vivo or a mixture thereof, and ornithine or a pharmaceutically acceptable salt or derivative thereof capable of effectively acting as ornithine in vivo or a mixture thereof in a ratio such that the amount of ornithine present in said mixture is at least about 1/1000 the amount of alanine present, both of said ornithine and alanine being present in an amount effective to prevent or alleviate said effects.